Newsbenzinga
What's Going On With Abivax Stock On Thursday?
· Published
Article summary
Abivax's Phase 3 ulcerative colitis data met remission goals, but cancer cases in the study raised safety questions and analyst caution.
An excerpt from the original article.
Comments —
Loading comments…